Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Equity Income: 2018-2020

Historic Equity Income for Arcus Biosciences (RCUS) over the last 3 years, with Dec 2020 value amounting to $1.2 million.

  • Arcus Biosciences' Equity Income was N/A to $1.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $256,000, marking a year-over-year change of. This contributed to the annual value of $613,000 for FY2020, which is 151.00% up from last year.
  • Per Arcus Biosciences' latest filing, its Equity Income stood at $1.2 million for Q4 2020, which was up 1,035.88% from -$131,000 recorded in Q2 2020.
  • Arcus Biosciences' Equity Income's 5-year high stood at $1.2 million during Q4 2020, with a 5-year trough of -$482,000 in Q1 2020.
  • Over the past 3 years, Arcus Biosciences' median Equity Income value was -$274,500 (recorded in 2018), while the average stood at -$147,300.
  • Its Equity Income has fluctuated over the past 5 years, first slumped by 172.85% in 2019, then surged by 68.20% in 2020.
  • Over the past 3 years, Arcus Biosciences' Equity Income (Quarterly) stood at -$323,000 in 2018, then tumbled by 91.94% to -$357,000 in 2019, then skyrocketed by 68.20% to $1.2 million in 2020.
  • Its Equity Income stands at $1.2 million for Q4 2020, versus -$131,000 for Q2 2020 and -$482,000 for Q1 2020.